Radiotherapy for nasopharyngeal cancer. 2022

P Blanchard, and J Biau, and F Huguet, and S Racadot, and C Berthold, and S Wong-Hee-Kam, and M-C Biston, and P Maingon
Département de radiothérapie oncologique, Gustave-Roussy, université Paris Saclay, 114, rue Édouard-Vaillant, 94800 Villejuif, France. Electronic address: pierre.blanchard@gustaveroussy.fr.

Nasopharyngeal cancers are a rarity in France. Radiotherapy is the cornerstone of treatment, frequently combined with chemotherapy. The technical modality of radiotherapy is complex in this disease, which is located in the vicinity of numerous organs at risk. In this article, we will present the updated guidelines of the French society for radiation oncology (Société française de radiothérapie oncologique, SFRO) on the indications, and technical details of radiotherapy in nasopharyngeal cancers.

UI MeSH Term Description Entries
D009303 Nasopharyngeal Neoplasms Tumors or cancer of the NASOPHARYNX. Cancer of Nasopharynx,Nasopharyngeal Cancer,Cancer of the Nasopharynx,Nasopharynx Cancer,Nasopharynx Neoplasms,Neoplasms, Nasopharyngeal,Cancer, Nasopharyngeal,Cancer, Nasopharynx,Cancers, Nasopharyngeal,Cancers, Nasopharynx,Nasopharyngeal Cancers,Nasopharyngeal Neoplasm,Nasopharynx Cancers,Nasopharynx Neoplasm,Neoplasm, Nasopharyngeal,Neoplasm, Nasopharynx,Neoplasms, Nasopharynx
D005602 France A country in western Europe bordered by the Atlantic Ocean, the English Channel, the Mediterranean Sea, and the countries of Belgium, Germany, Italy, Spain, Switzerland, the principalities of Andorra and Monaco, and by the duchy of Luxembourg. Its capital is Paris. Corsica,Saint Pierre and Miquelon,Miquelon and Saint Pierre,Miquelon and St. Pierre,St. Pierre and Miquelon
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D012955 Societies, Medical Societies whose membership is limited to physicians. Medical Societies,Medical Society,Society, Medical
D058958 Organs at Risk Organs which might be damaged during exposure to a toxin or to some form of therapy. It most frequently refers to healthy organs located in the radiation field during radiation therapy. Organs at Risks,Risk, Organs at,Risks, Organs at,at Risk, Organs,at Risks, Organs
D018787 Radiation Oncology A subspecialty of medical oncology and radiology concerned with the radiotherapy of cancer. Oncology, Radiation,Radiology, Therapeutic,Therapeutic Radiology
D035583 Rare Diseases A large group of diseases which are characterized by a low prevalence in the population. They frequently are associated with problems in diagnosis and treatment. Orphan Diseases,Disease, Orphan,Disease, Rare,Orphan Disease,Rare Disease

Related Publications

P Blanchard, and J Biau, and F Huguet, and S Racadot, and C Berthold, and S Wong-Hee-Kam, and M-C Biston, and P Maingon
May 1971, Gan no rinsho. Japan journal of cancer clinics,
P Blanchard, and J Biau, and F Huguet, and S Racadot, and C Berthold, and S Wong-Hee-Kam, and M-C Biston, and P Maingon
January 1986, Rinsho hoshasen. Clinical radiography,
P Blanchard, and J Biau, and F Huguet, and S Racadot, and C Berthold, and S Wong-Hee-Kam, and M-C Biston, and P Maingon
March 2010, International journal of radiation oncology, biology, physics,
P Blanchard, and J Biau, and F Huguet, and S Racadot, and C Berthold, and S Wong-Hee-Kam, and M-C Biston, and P Maingon
January 2007, International journal of radiation oncology, biology, physics,
P Blanchard, and J Biau, and F Huguet, and S Racadot, and C Berthold, and S Wong-Hee-Kam, and M-C Biston, and P Maingon
January 1997, Oral oncology,
P Blanchard, and J Biau, and F Huguet, and S Racadot, and C Berthold, and S Wong-Hee-Kam, and M-C Biston, and P Maingon
July 1987, Rinsho hoshasen. Clinical radiography,
P Blanchard, and J Biau, and F Huguet, and S Racadot, and C Berthold, and S Wong-Hee-Kam, and M-C Biston, and P Maingon
January 2015, Voprosy onkologii,
P Blanchard, and J Biau, and F Huguet, and S Racadot, and C Berthold, and S Wong-Hee-Kam, and M-C Biston, and P Maingon
February 2021, JAMA oncology,
P Blanchard, and J Biau, and F Huguet, and S Racadot, and C Berthold, and S Wong-Hee-Kam, and M-C Biston, and P Maingon
February 2021, JAMA oncology,
P Blanchard, and J Biau, and F Huguet, and S Racadot, and C Berthold, and S Wong-Hee-Kam, and M-C Biston, and P Maingon
September 2016, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique,
Copied contents to your clipboard!